Severe Vasculitis Yields to Rituximab (CME/CE)
(MedPage Today) — The B-cell depleting agent rituximab (Rituxan) effectively alleviates serious manifestations of cryoglobulinemic vasculitis, two groups of researchers found.
Article printed from Gastroenterology Education and CPD for trainees and specialists: http://www.gastrotraining.com